Search research articles
Contact Us
Filters
Showing results (31-40 of 36) with videos related to
Page
of 4
Sort By:
You have reached the last page of results.
This site can display upto 36 results.
Pathology
|
February 28, 2021
NKX3.1 immunohistochemistry is highly specific for the diagnosis of mesenchymal chondrosarcomas: experience in the Australian population
Nimeka Ramanayake, Ana Cristina Vargas, Joel Talbot, et al.
Histopathology
|
January 19, 2021
DNA damage-inducible transcript 3 immunohistochemistry is highly sensitive for the diagnosis of myxoid liposarcoma but care is required in interpreting the significance of focal expression
Ana Cristina Vargas, Noni L Chan, Daniel D Wong, et al.
JCO Precision Oncology
|
June 27, 2024
Keratin-Positive Giant Cell Tumor of Bone and Soft Tissue With <i>HMGA2::NCOR2</i> Fusion in Children Under 10 With Response to Imatinib Therapy: A Case Series
Phassawan Rungsiprakarn, Anne L Ryan, Daniel D Wong, et al.
Cancer Medicine
|
February 18, 2022
Systemic treatments and outcomes in CIC-rearranged Sarcoma: A national multi-centre clinicopathological series and literature review
Elizabeth A Connolly, Vivek A Bhadri, Johnathon Wake, et al.
European Journal of Cancer (Oxford, England : 1990)
|
March 12, 2026
Pleomorphic rhabdomyosarcoma, outcomes of patients with advanced disease treated with systemic agents: Retrospective study from the global pushing ultra-rare sarcomas towards hope (PUSH) consortium
Giacomo G Baldi, Claudia Giani, Silva Ljevar, et al.
The American Journal of Surgical Pathology
|
October 28, 2024
International Multicenter Retrospective Study From the Ultra-rare Sarcoma Working Group on Low-grade Fibromyxoid Sarcoma, Sclerosing Epithelioid Fibrosarcoma, and Hybrid Forms: Outcome of Primary Localized Disease
Claudia Giani, Abdulazeez Salawu, Silva Ljevar, et al.
Page
of 4
Search research articles
Search
Showing results (31-40 of 36) with videos related to
Sort By:
Page
of 4
You have reached the last page of results.
This site can display upto 36 results.
Pathology
|
February 28, 2021
NKX3.1 immunohistochemistry is highly specific for the diagnosis of mesenchymal chondrosarcomas: experience in the Australian population
Nimeka Ramanayake, Ana Cristina Vargas, Joel Talbot, et al.
Histopathology
|
January 19, 2021
DNA damage-inducible transcript 3 immunohistochemistry is highly sensitive for the diagnosis of myxoid liposarcoma but care is required in interpreting the significance of focal expression
Ana Cristina Vargas, Noni L Chan, Daniel D Wong, et al.
JCO Precision Oncology
|
June 27, 2024
Keratin-Positive Giant Cell Tumor of Bone and Soft Tissue With <i>HMGA2::NCOR2</i> Fusion in Children Under 10 With Response to Imatinib Therapy: A Case Series
Phassawan Rungsiprakarn, Anne L Ryan, Daniel D Wong, et al.
Cancer Medicine
|
February 18, 2022
Systemic treatments and outcomes in CIC-rearranged Sarcoma: A national multi-centre clinicopathological series and literature review
Elizabeth A Connolly, Vivek A Bhadri, Johnathon Wake, et al.
European Journal of Cancer (Oxford, England : 1990)
|
March 12, 2026
Pleomorphic rhabdomyosarcoma, outcomes of patients with advanced disease treated with systemic agents: Retrospective study from the global pushing ultra-rare sarcomas towards hope (PUSH) consortium
Giacomo G Baldi, Claudia Giani, Silva Ljevar, et al.
The American Journal of Surgical Pathology
|
October 28, 2024
International Multicenter Retrospective Study From the Ultra-rare Sarcoma Working Group on Low-grade Fibromyxoid Sarcoma, Sclerosing Epithelioid Fibrosarcoma, and Hybrid Forms: Outcome of Primary Localized Disease
Claudia Giani, Abdulazeez Salawu, Silva Ljevar, et al.
Page
of 4